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Abstract 
 Disorders of anxiety and depression are major public health problems evident by their 
increasing prevalence and lack of effective treatments. These disorders are highly comorbid and 
share several debilitating symptoms. Previous research has implicated ketamine in the treatment 
of depression because of its rapid effects. Ketamine is a noncompetitive NMDA receptor 
antagonist that stimulates glutamate transmission. The efficacy of non-competitive NMDA 
receptor antagonists in anxiety treatment, however, lacks consistent findings. The goal of the 
present study was to examine the effects of repeated ketamine administration during rat 
adolescence on anxiety and depressive-like behaviors induced by a predator odor.  
The use of animal models of anxiety is essential to understanding the neuropathology of 
anxiety and depression and developing new drug treatments. A common non-invasive animal 
model of anxiety involves exposing the animal to the odor of a natural predator. Ketamine was 
administered from PND 45-51, which is considered a conservative age range for adolescence 
(Spear, 2000). On PND 65, half of the rats were exposed to the odor of a domestic cat, which 
was presented via cat collars and hand towels attached to the home cage. All animals were then 
subjected to the sucrose preference test (SPT) and the elevated zero maze (EZM) in order to 
measure the presence of depressive and anxiety-like behaviors, respectively. There was a drug x 
odor interaction effect trending toward significance in the habitation phase of the SPT, indicating 
that the ketamine reversed the reduction in sucrose preference due to the predator odor. There 
were no significant results from the test phase of the SPT. The elevated zero maze was 
conducted on two consecutive days. Results for day 2 of EZM testing revealed a significant main 
effect of odor indicating that the rats exposed to the predator odor made significantly fewer 
entries into the open quadrants compared to the rats exposed to the control odor. The results 
demonstrate that ketamine only influenced depressive-like behaviors, thus indicating dissociation 
between the drug’s effect on models of depression and anxiety. Overall, the results provide some 
support for the preventative effects of ketamine on depressive-like behaviors. 
 
 
 
 
 
 
 
 
 
 
 	   1	  
The Effects of Repeated Ketamine Administration During Adolescence on Anxiety and 
Depressive-like Behaviors Induced by a Predator Odor 
Disorders of anxiety share features of excessive fear and anxiety as well as related 
behavioral disturbances. Generalized anxiety disorder (GAD) is defined as excessive anxiety and 
worry, occurring more days than not for at least 6 months, about a number of events or activities, 
such as work or school performance (Diagnostic and Statistical Manual of Mental Disorders, 5th 
ed.; DSM-5; American Psychiatric Association, 2013). Approximately 19.1 million, or about 
13.3%, American adults ranging in age from 18 to 54 have an anxiety disorder (Bener, Ghuloum, 
& Abou-Saleh, 2012). The World Health Organization projects disorders of anxiety to become 
one of the top two most burdensome disorders in the world by the year 2020 (Yang et al., 2012). 
Although effective treatments exist, many individuals can suffer for years after treatment onset. 
Between 20 and 50% of patients do not respond to drug treatment depending upon the specific 
disorder (Nordquist, Steckler, Wettstein, Mackie, & Spooren, 2008). When left untreated, 
anxiety disorders can lead to long-term disability (Kroenke, Spitzer, Williams, Monahan, & 
Lowe, 2007) and substantial social burden (Bener & Ghuloum, 2010). Furthermore, chronic 
stress can lead to premature death (Kroenke et al., 2007) due to an increased risk for upper 
respiratory infection, accelerated progression of coronary artery disease, and a more severe 
course for autoimmune disorders (Miller, Chen, & Zhou, 2007). 
Depression is a major public health problem evidenced by its high ranking among the 
global burden of diseases (Bener et al., 2012). Major depressive disorder (MDD) afflicts 
approximately 17-20% of the population and is a leading cause of disability and economic 
hardship (Garcia et al., 2009). Among those suffering from MDD, 75-80% have recurrent 
episodes (Mueller et al., 1999) and 10-30% do not reach complete symptom remission (Mann, 
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2005). MDD is defined as displaying five or more of the following symptoms for a period of two 
weeks nearly every day: depressed mood, markedly diminished interest in almost all activities, 
significant weight loss or decrease in appetite, insomnia or hypersomnia, psychomotor agitation 
or retardation, fatigue or loss of energy, feelings of worthlessness or excessive or inappropriate 
guilt, diminished ability to think or concentrate, or recurrent thoughts of death (5th ed., DSM-5; 
American Psychiatric Association, 2013). Additionally, depression is one of the most costly 
psychopathologies and is a leading cause of morbidity and mortality worldwide (Garcia et al., 
2009). While the underlying pathology associated with depression is still unknown, some 
researchers believe it could result from molecular and cellular anomalies that interact with 
environmental and genetic factors (Krishnan & Nestler, 2008). 
The current pharmacotherapies available for treating depression include tricyclic 
antidepressants, selective serotonin reuptake inhibitors, serotonin–noradrenergic reuptake 
inhibitors, and other atypical antidepressant drugs such as monoamine oxidase inhibitors 
(MAOIs; Nemeroff, 2007). Unfortunately, the efficacy of these antidepressants is often 
unreliable, and many of them produce unwanted side effects including fatigue, sleep disturbance, 
tremor, sweating, loss of appetite, weight gain, and sexual dysfunction (Kikuchi, Uchida, Suzuki, 
Watanabe, & Kashima, 2011). The most serious limitation of current antidepressants is that they 
require a few weeks to months to induce a therapeutic response, and only about one third of 
patients respond to their first prescribed antidepressant (Li et al., 2010). This is problematic 
because depression is associated with high rates of suicide and is projected to become the second 
leading cause of death worldwide by the year 2020 (Rosenzweig-Lipson et al., 2007). Thus, there 
is an ever-increasing need for more effective and better-tolerated antidepressants. 
Anxiety and Depression Comorbidity 
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 The comorbidity of anxiety disorders and depressive disorders has been widely 
investigated. More than 80% of patients suffering from anxiety will have a comorbid mental 
illness during their lifetime. The prevalence of having a current comorbid axis I disorder is 50%, 
with anxiety and depressive disorders being the most common comorbid disorders (Brown, 
Campbell, Lehman, Grisham, & Mancill, 2001). Anxiety and depression share many common 
symptoms including irritability, loss of sleep and appetite, lethargy, and disruptions in social and 
cognitive functioning. However, each disorder has one unique symptom that allows for 
differentiation between the two disorders. Anxiety disorders can be diagnosed by the presence of 
unrealistic and excessive worry and/or fear (McGrandles & Duffy, 2012), and depression can be 
diagnosed by the core symptom of anhedonia (Pohl, Olmstead, Wynne-Edwards, Harkness, and 
Menard, 2007). People suffering from both anxiety and depression experience more disability 
and distress compared to people suffering from only one of these disorders (Cairney, Corna, 
Veldhuizen, Herrmann, & Streiner, 2008).  
There exists some inconsistencies regarding the comorbidity rate mainly due to varying 
symptoms among patients. In 2004, the American Psychiatric Association reported that 
approximately 90% of patients with GAD have at least one other mental disorder, with 50% also 
having a major depressive episode by age 18 (4th ed., DSM-5; American Psychiatric Association, 
1994). Hek and colleagues (2011) conducted a study investigating the number of people with 
anxiety disorders who also suffer from current depression. They found that of all the people with 
a current anxiety disorder, 17.9% currently had comorbid depression. In contrast, only 2.8% of 
people without an anxiety disorder had current depression. Comorbidity between depression and 
an anxiety disorder is associated with greater psychiatric symptom severity (Cyranowski et al., 
2012; Klein Hofmeijer-Sevink et al., 2012). In a study conducted by Cyranowski and colleagues, 
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data from 915 women aged 42 to 52 with a comorbid history of MDD and anxiety reported 
greater symptom severity, diminished social support, and more distressing life events in the past 
year compared to women with either MDD or anxiety alone. 
Anxiety and Its Underlying Neural Mechanisms 
Stress is an important risk factor for the development of certain psychopathologies, 
including anxiety disorder (Nestler et al., 2002). Scientists have been trying to understand the 
biological mechanisms involved in chronic stress that cause adverse psychological outcomes. 
One possible mechanism that has been gaining widespread support is the hypothalamic-pituitary-
adrenal (HPA) axis. This system exists within all mammals and becomes activated in the 
presence of mental and physical stressors. When an animal of prey detects a nearby predator, 
neurons in the paraventricular nucleus of the hypothalamus secrete corticotropin-releasing 
hormone. This secretion causes the release of adrenocorticotropin hormone (ACTH) from the 
anterior pituitary, concluding in the secretion of glucocorticoids (cortisol in humans and 
corticosterone in rodents) from the adrenal glands into the circulatory system (Kalynchuk, 
Gregus, Boudreau, & Perrot-Sinal, 2004). Due to ethical issues that arise from human research, 
animal models are indispensable for investigating the biological bases of anxiety disorders and 
therefore developing better pharmacological and behavioral therapies (Steimer, 2011). Research 
has shown that a 30-minute exposure to predator odor activates HPA axis output in adult rats 
(Masini, Sauer, & Campeau, 2005).  
 When stress is present, the hypothalamus releases hormones that create a threat to the 
animal’s state of equilibrium. During this period, the animal experiences physiological changes 
including increased heart rate, blood pressure, and muscle tension. Although anxiety typically 
has a negative connotation, a small degree of anxiety can be beneficial: it can enhance 
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performance on a test or heighten an individual’s awareness to protect him or herself from 
danger (McGrandles & Duffy, 2012). This physiological mechanism has survival value because 
it prepares the animal for flight or fight. When the danger is no longer threatening, these elevated 
levels subside and the organism returns to a pre-stress level of functioning. Thus, normal HPA 
axis activation is necessary for survival because it helps the body sustain a state of equilibrium 
(Kalynchuk et al., 2004). If successful adaptation to stress does not occur, the body maintains 
this state of hyperarousal and chemical imbalance (Miller et al., 2007). Sustaining this 
emergency state can have deleterious physiological effects and damage normal brain functioning 
(Kalynchuk et al., 2004). For example, research has found that exposing a rat to high levels of 
corticosterone (CORT) reduces dendritic branching of CA3 pyramidal neurons, decreases 
hippocampal neurogenesis, and decreases hippocampal glucocorticoid receptor mRNA 
expression (Fuchs & Gould, 2000; Vyas, Mitra, Rao, & Chattarji, 2002). Altered synaptic 
transmission in the hippocampus has been implicated in both GAD and post-traumatic stress 
disorder (Chen & Etkin, 2013). 
There is a consistent body of literature discerning the action of cortisol in response to 
stress. Studies have demonstrated that the HPA axis becomes activated and leads to a subsequent 
increase in ACTH and cortisol immediately following a stressful event. As time passes, cortisol 
secretion rebounds to below normal levels in an attempt to counteract the initial activation 
(Miller et al., 2007). Changes in cortisol concentrations affect important physiological processes 
including immunity, growth, reproduction, and metabolism (Kallen et al., 2008). The time-
dependent pattern of cortisol is consistent with studies conducted by several researchers (Fries, 
Hesse, Hellhammer, & Hellhammer, 2005; Miller, Cohen, & Ritchey, 2002). Cortisol has 
widespread regulatory influences due to its involvement in learning, memory, and emotion in the 
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central nervous system (CNS). Additionally, it regulates glucose storage and usage in the 
metabolic system, and regulates the maturation of lymphocytes and the magnitude of 
inflammatory responses in the immune system. Scientists have demonstrated that cortisol is the 
primary biological mechanism through which chronic stressors negatively affect the body. 
Accumulated stress plays a role in the onset of mental health disorders such as depression and 
schizophrenia as well as physiological illnesses such as cancer, arthritis, diabetes, and obesity. 
Researchers believe that stress triggers an increase in cortisol secretion, thereby exposing bodily 
tissue to an overabundance of the hormone. When this exposure is chronic or sustained, there is 
subsequent tissue damage and dysregulation of biological systems (Kalynchuk et al., 2004; 
Miller et al., 2007; Campeau, Nyhuis, Sasse, Day, & Masini, 2008; Wright, Muir, & Perrot, 
2013). 
The amygdala is the brain structure most frequently implicated in the temporary 
expression of fear (Pietersen et al., 2006). Current research is investigating methods of fear 
extinction in animals with the goal that such treatments might be effective in facilitating 
exposure-based therapy for individuals with clinical anxiety disorders (Davis, Myers, Chhatwal, 
& Ressler, 2006). Human imaging studies utilizing functional magnetic resonance imaging and 
positron emission tomography (PET) have demonstrated increased blood flow to the amygdala in 
the presence of conditioned and unconditioned fearful stimuli. If the amygdala is damaged or 
inactivated, the animal will not acquire or express conditioned fear responses (Davis et al., 
2006). The particular amygdalar subregions involved in this biological system have yet to be 
established, although many studies have implicated the role of the central nucleus of the 
amygdala (CeA) in the expression of autonomic responses. The basolateral nucleus (BA) sends 
ϒ-aminobutyric acid (GABA) interneurons to the CeA which then send interneurons to the 
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hypothalamus, brain stem, and basal forebrain regions that directly control autonomic, hormonal 
and behavioral responses to emotional stimuli (Forster, Novick, Scholl, & Watt, 2012). Thomas, 
Burock, Knudsen, Deterding, and Yadin (2013) examined single unit activity in the lateral 
septum (LS) and CeA in the elevated plus maze (EPM). The EPM is a measure of behavioral 
anxiety that consists of two enclosed arms and two open arms, thus forming a cross. An animal 
that spends more time in the enclosed arms compared to the open arms is said to be 
demonstrating anxiety-like behavior. They found that when the animals were exposed to the 
EPM, there was a decrease in CeA firing and an increase in LS firing when standing in the open 
arms. These results suggest that when placed in the open arms, a compensatory process takes 
place that suppresses fear in order for the rat to employ adaptive behavior.  
The monoamine neurotransmitters, dopamine (DA), serotonin (5-HT), and 
norepinephrine (NE), have been linked to disorders of anxiety. Drugs that alter monoaminergic 
transmission tend to be effective treatments for anxiety disorders. Several studies have shown 5-
HT (Inoue, Koyama, & Yamashita, 1993), DA, and NE activation immediately following foot 
shock, restraint, and fear conditioning (Emoto et al., 1993; McIntyre, Hatfield, & McGaugh, 
2002; Yokoyama et al., 2005). The dorsal raphe nucleus gives rise to 5-HT that innervates the 
amygdala, while the locus coeruleus and ventral tegmental area give rise to NE and DA, which 
then innervate the amygdala (Forster et al., 2012). This research stimulated the development of 
anxiolytics that work by enhancing GABAergic transmission (Wierońska, Nowack, & Pilc, 
2010). Although these GABA-enhancing drugs (benzodiazepines and antidepressants) are 
effective, some patients do not respond to this treatment, which has led researchers to uncover 
alternative target receptors for treating anxiety.  
The N-methyl-D-aspartate (NMDA) receptor has recently been considered as a target for 
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treating anxiety because the underlying pathologies of many neurodegenerative and psychiatric 
disorders are linked to glutamate imbalance. Because glutamate is the main excitatory 
neurotransmitter in the CNS, its function is to maintain normal brain functioning involving 
cognition, memory, and learning. Glutamate binds to the NMDA receptor and has high 
concentrations in the amygdala. Due to the high comorbidity rate between anxiety and 
depression, NMDA receptor antagonists also have been considered for treating depression. 
Additionally, the questionable efficacy of MAOIs necessitates a treatment that acts on a different 
neural pathway. MAOIs block the reuptake or breakdown of monoamines, thereby acting on the 
neuromodulatory systems (Duman & Voleti, 2012). In contrast, NMDA receptor antagonists 
work to increase glutamate transmission and the induction of synaptogenesis (Li et al., 2010).  
Depression and Its Underlying Neural Mechanisms 
 The major brain regions involved in regulating mood include the prefrontal cortex (PFC), 
the hippocampus, and the amygdala. Many clinical studies have shown that stress and depression 
are associated with atrophy of neurons and glia, which lead to a reduced size and function of the 
limbic regions, including the PFC and hippocampus (Li et al., 2010). Additionally, magnetic 
resonance imaging and PET studies consistently report that decreased PFC and hippocampus 
volume sizes precipitate illness and are associated with a longer duration of ailment (Savitz & 
Drevets, 2009). The decreased size of the PFC is due to a reduction in pyramidal neuron volume 
as well as a decrease in the number of GABAergic interneurons and glia (Rajkowska, O'Dwyer, 
Teleki, Stockmeier, & Miguel-Hidalgo, 2007). These findings support the claim that depression 
is a neurodegenerative disorder, although neuronal decline can be ameliorated by treatment and 
stress alleviation (Duman & Voleti, 2012). The amygdala, on the other hand, experiences a 
somewhat different alteration in depression. Instead of neuronal atrophy, studies of the amygdala 
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have shown neuronal hypertrophy, including increased dendrite complexity in the BA 
(Roozendaal, McEwen, & Chattarji, 2009). This hyperactive state can lead to increased anxiety, 
fear, and emotion (Sotres-Bayon & Quirk, 2010).  
One theory regarding the underlying pathophysiology of MDD involves brain-derived 
neurotrophic factor (BDNF). BDNF is the most abundant neurotrophin in the CNS among 
mammals and the most studied neurotrophin in the pathophysiology of MDD (Machado-Vieira et 
al., 2009). Neurotrophins are a multigene family of polypeptide growth factors that exert their 
effects by binding to receptors on the surface of responsive cells (O’Hanlon, Mabry & Ekekezie, 
2014). Postmortem studies have found that depressed patients have reduced hippocampal and 
cortical BDNF levels, which is consistent with the down-regulation of BDNF in the presence of 
stress (Altar, 1999). Evidence from animal studies indicates that environmental stressors lead to 
the onset of depression by suppressing BDNF gene expression in the hippocampus. Bai and 
colleagues (2012) investigated whether stressors that alter hippocampal BDNF expression and 
subsequent depressive behavior vary with different stressors. The researchers utilized two 
classical chronic stress paradigms: maternal deprivation (MD) and chronic unpredictable stress 
(CUS) to test the role of BDNF in early life stress in Sprague-Dawley rats. They found that 
BDNF protein expression tended to be the lowest in the MD group and that the MD and CUS 
groups floated for a significantly longer time in the forced swim test (FST) compared to controls. 
In conclusion, the down-regulation of the BDNF gene in the hippocampus indicates that different 
stressor-induced depressive phenotypes may result from dissimilar molecular foundations.  
Most antidepressants work by increasing the level of biogenic amines including NE, DA, 
and 5-HT via blocking reuptake or inhibiting degradation (Ates-Alagoz & Adejare, 2013). 
Although these medications are able to successfully stabilize mood for many individuals, only 
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one third of all depressed patients have considerable improvement with a standard antidepressant 
after two months. Additionally, many patients have to deal with undesirable side effects (Rush et 
al., 2006). Antidepressants also produce therapeutic effects by reducing inflammatory responses. 
Based on this information, researchers posit that the etiology of depression is associated with an 
elevated expression of proinflammatory cytokines (Yang et al., 2012). Developing a more 
effective antidepressant remains a challenge because the target receptor has yet to be identified. 
Even more challenging is trying to figure out why an antidepressant will exert a therapeutic 
effect in one individual but not in a different individual. While NMDA receptor antagonists have 
been shown to produce rapid, antidepressant effects, the mechanisms underlying antidepressant 
action are more complicated than NMDA receptor blockage and have yet to be discovered.  
 Although the pathophysiology of depression remains unknown, several studies have 
demonstrated that the ionotropic glutamate NMDA receptor plays a major role in the etiology of 
depression (Javitt, 2004). Dysfunction of the glutamate neurotransmitter system is due to altered 
levels of glutamate in the blood, cerebral spinal fluid, and brains in patients with MDD and 
bipolar disorder (Hashimoto, Sawa, & Iyo, 2007). Over-stimulation of NMDA receptors leads to 
an excessive Ca2+ influx that is implicated in many neurodegenerative diseases (Ates-Alagoz & 
Adejare, 2013). Several studies have identified the NMDA receptor as a target for fast-acting 
antidepressants. Ketamine has been implicated in treating depression because it is a 
noncompetitive antagonist of the NMDA calcium pore. Recent research has found that acute and 
chronic doses of ketamine exerted prolonged antidepressant-like effects evidenced by decreased 
immobility in the FST, an animal measure of depression, as well as increased NMDA receptor 
density in the hippocampus (Tizabi, Bhatti, Manaye, Da Sa, & Akinfiresoye, 2012). Further 
evidence for the glutamate theory is derived from preclinical studies that have shown that 
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NMDA receptor antagonists such as MK-801, CPP, AP7 and neramexane exert anxiolytic and 
antidepressant effects in rats when injected into specific brain regions (Kos, Legutko, Danysz, 
Samoriski, & Popik, 2006; Molchanov & Guimarães, 2002; Menard & Treit, 2000). 
Ketamine is a noncompetitive NMDA receptor antagonist that stimulates glutamate 
transmission (Autry et al., 2011). Because the effects of ketamine are dose dependent, this drug 
has a variety of uses. At higher doses, ketamine is used as a general anesthetic in medical and 
veterinary clinics. Since the 1960s, ketamine has been classified as a “dissociative anesthetic” 
because of its sedative and hallucinogenic properties. In addition, it is commonly used as an 
anesthetic in pediatric surgery because of its bronchodilating effects and is part of the anesthetic 
procedures commonly used in electroconvulsive shock therapy in the cases of severe depression 
(Engin, Treit, & Dickson, 2009). At lower, sub-anesthetic doses, ketamine is able to mimic the 
effects of an antidepressant (Zarate et al., 2006). It was originally considered for use as an 
antidepressant due to its unique ability to block the NMDA receptor. Unlike other NMDA 
antagonists, ketamine has slower open-channel blocking, a “trapping block” type of channel 
closure, and a nonselective blockade of voltage-dependent calcium channels along with opioid, 
monoaminergic, and muscarinic receptors (Garcia et al., 2009). Although the evidence for 
ketamine’s antidepressant-like effects are compelling, there is a lack of double-blind, placebo-
controlled studies. Additional studies must be conducted to assess the severity of ketamine’s 
psychoactive and euphoric effects at clinical doses (Popik, Kos, Sowa-Kućma, & Nowak, 2008). 
Previous research investigating the effectiveness of non-competitive NMDA receptor 
antagonists has revealed inconsistent results. Recent research, however, has been providing 
robust evidence for ketamine’s anxiolytic effects. For example, Pietersen and colleagues (2006) 
investigated how acute NMDA receptor blockage with ketamine affects frequency and duration 
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of freezing as well as associated neural changes in the amygdala, PFC, and hippocampus in fear-
conditioned rats. The results indicated that ketamine normalized stress-related behaviors in areas 
associated with fear and anxiety. Amann and colleagues (2009) found that a chronic, low dose of 
ketamine reduced freezing behavior in a context fear-conditioning paradigm in ketamine-treated 
mice as compared with saline-treated mice. Parallel with these findings are those from an 
experiment conducted by Loss, Córdova, and Oliveira (2012) who found that ketamine 
administration 15 and 60 minutes after pilocarpine administration (a cholinergic agonist) 
significantly increased time spent in the open arms of the EPM compared to the ketamine-only 
groups. 
As previously mentioned, a major limitation of current antidepressant treatment is that 
monoaminergic-based drugs require two to three weeks to exert a therapeutic effect (Maeng et 
al., 2008). The clinical use of ketamine has gained broad attention because of its rapid (within 
two hours) therapeutic effects, as well as effects that last for a significant amount of time after a 
single dose in treatment-resistant patients (Zarate et al., 2006). It has been known for over 15 
years that NMDA receptor antagonists produce antidepressant effects after a single 
administration, evident by measures such as the FST and the tail suspension test (TST; Popik et 
al., 2008). Ketamine’s antidepressant effects after acute administration have been well 
established. Li and colleagues (2012) found that acute treatment with a non-competitive NMDA 
channel blocker and the NR2B antagonist, Ro25-6981, tends to improve anhedonia and 
anxiogenic behaviors induced by chronic mild stress. In order to provide more compelling 
evidence for human application, future research must investigate the efficacy of long-term 
treatment paradigms. 
Drug Administration in Adolescence  
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Early life experiences can have a profound effect on an individual’s psychological 
functioning as an adult. A great deal of research seeks to understand how drug administration 
during adolescence affects human behavior and neurobiology during adulthood. The primary 
focus of these studies has been on nicotine and ethanol, as both are widely abused during the 
teenage years (Spear & Varlinskaya, 2005). Age-dependent alcohol studies have demonstrated 
how adolescent alcohol abuse increases the risk for, or vulnerability to, certain disorders in 
adulthood. Although ethanol and nicotine are the most commonly abused drugs in adolescence, 
other drugs including marijuana, ‘club drugs’, and inhalants are also frequently abused by 
adolescents (Wiley, Evans, Grainger, & Nicholson, 2008). Ketamine is one of the most 
dangerous club drugs because of its toxic effect on the CNS (Warren et al., 2006). Wiley, Evans, 
Grainger, and Nicholson (2011), investigated the acute and repeated effects of ketamine and 
other ‘club drugs’ in female adolescent and adult rats. They found that ketamine did not alter 
activity acutely but did increase ambulatory activity when administered sub-chronically. A few 
years later, Parise and colleagues (2013) found that ketamine administration in adolescence 
[postnatal day (PND) 35] reversed the effects of CUS-induced depressive-like behaviors in the 
FST. In conclusion, these studies illustrate the potential for development of psychopathologies in 
adulthood as a function of drug administration during adolescence.  
The present study will be utilizing an animal model of anxiety to expose rats to the 
stressor of predator odor. As discussed by Spear (2000), the age span of adolescence in 
nonhuman animals is often debated among researchers in the field. Conclusions regarding the 
boundaries of adolescence have not been reached because of variations in gender and growth rate 
within individual species. Additionally, limited research on biosociobehavioral function during 
this time period has been conducted. Most research on adolescence focuses on the 
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neuroendocrinology of puberty and the catalysts of these changes. A conservative age range for 
adolescence in rats is PND 28-42, which was derived from measures such as timing of growth 
spurt, loss of amino acid influx to the PFC, and the timing rats emerge from the protected burrow 
in their natural habitat. The margins of this conservative age range do not imply that animals 
younger or older than this range are not experiencing some adolescent transitioning. For 
example, females may experience ontogenetic changes reflective of adolescence as early as 20 
days. Additionally, males can display signs of puberty as late as 55 days. Using a broader range 
of adolescence is wise, especially in experiments designed to expose the animals to a treatment 
for the entire ontogenetic window. The commonly used age range for rat adulthood is PND 70-
90, which follows a late adolescence age range from PND 35-55 (Broadwater & Spear, 2013).  
 
Animal Models of Anxiety 
Exposure to Predator Odor Paradigm 
Animal models of anxiety are essential to understanding the neuropathology of anxiety 
and depression and developing new drug treatments. There are several ways to model human 
anxiety disorders in rodents including repeated CORT injections (Kalynchuk et al., 2004), 
chronic psychosocial stress models (Slattery et al., 2012) and repeated footshock (Kassai & 
Gyertyán, 2012). Although these methods are effective models of anxiety, another approach is to 
utilize natural fear-inducing stimuli that have greater ethological relevance. One currently 
popular model is the use of predator odors to provoke defensive behaviors. Laboratory rats, in 
particular, are instinctively fearful of live cats and their fur/skin odor. Although the type of 
predator odor and defensive mechanism employed are species-specific, defensive behaviors 
occur and have survival value for all mammals when faced with a potentially dangerous 
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environmental threat.  
Exposure to a predator odor is a paradigm used to understand the neurobiology of anxiety 
in animal models. Predator odors have an advantage over other stressor models in that they cause 
no pain or physical injury to the animal. In addition, the behavioral and endocrine response to the 
odor is innate, meaning the rats do not need to be trained to respond to the stimulus (Masini et 
al., 2005). The predator odor exposure paradigm uses the principles of unconditioned fear to 
assess the frequency of defensive behaviors to the odor of a predator. There are several ways to 
conduct a predator odor paradigm for rodents including exposure to 2,4,5-trimethlythiazoline 
(TMT), ferret skin/fur odor, and cat skin/fur odor. 
TMT 
TMT is the synthetic version of a stimulus naturally present in the feces of red foxes 
(Vulpes vulpes; Fendt, Endres, Lowry, Apfelbach, & McGregor, 2005). A major advantage of 
TMT over alternative methods is the quantifiable nature of this synthetically derived odor. 
Unlike cat and ferret odor, the stimulus intensity (concentration and volume) can be easily 
controlled and emulated. Several studies have demonstrated the ability of TMT to induce 
physiological changes in rodents, such as induction of serum corticosterone (Morrow, Elsworth, 
& Roth, 2002) and behavioral modifications including changes in food consumption (Endres, 
Apfelbach, & Fendt, 2005), avoidance, freezing, and risk assessment behaviors (Hacquemand, 
Choffat, Jacquot, & Brand, 2013). For example, in a study conducted by Hebb and colleagues 
(2004), mice exposed to TMT displayed significant defensive behaviors including freezing and 
anxiogenic behaviors in the light-dark test. However, one major disadvantage of this method is 
that not all laboratories that employ TMT exposure are able to induce fear using this synthetic 
derivative (Endres & Fendt, 2007; Wallace & Rosen, 2000; Blanchard et al., 2003). In addition, 
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it has been noted that using odors derived from feces are not as effective as using odor from fur 
because feces can be found long after a predator has departed, thereby reducing their utility as an 
indicator of the presence of a predator. In addition, predators tend to defecate in areas where they 
do not hunt, thereby eliminating the threat of an impending attack. Another disadvantage of 
using TMT is that it produces less clear and robust effects than that of cat/fur odor. For example, 
Morrow, Redmond, Roth, and Elsworth (2000) found that TMT exposure did not alter any motor 
behaviors (immobility, grooming, rearing), however, all of these behaviors were significantly 
affected by a tone-conditioned footshock.  
Ferret Odor 
Another predatory odor that can be used to evoke anxiety in the rat is ferret odor. The 
ferret (Putorius putorius furo) belongs to the carnivorous family, Mustelidae, and is a natural 
predator of rats (Apfelbach, 1978). The odor is generally obtained by placing a cotton hand towel 
in a cage with one male and one female adult ferret for one month. The towel is then cut into 
5cm x 5cm square pieces and stored in an -80°C freezer until the day of testing (Campeau et al., 
2008). Ferret odors activate certain brain structures in rodents including the olfactory system, the 
PFC, the amygdala, and certain areas of the hypothalamus that play a role in the defensive circuit 
(Staples, 2010). Additionally, they have been shown to elicit endocrine responses and behavioral 
changes including increased hiding and risk assessment (Masini et al., 2005). McIntyre, Kent, 
Hayley, Merali, and Anisman (1999) demonstrated that ferret odor alters an animal’s physiology 
state due to increases in plasma CORT and ACTH levels. Additionally, both stressors (restraint 
and ferret odor) altered NE, DA, and 5-HT mean levels in brain regions associated with stress. 
Masini and colleagues (2005) found that ferret odor successfully evoked HPA axis activation as 
evidenced by elevated CORT and ACTH levels. Additionally, rats exposed to ferret odor in a 
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defensive withdrawal paradigm exhibited more avoidance and risk assessment behaviors 
compared to rats exposed to the control odor. Finally, brain activation was evident after a single 
30-min odor exposure in the LS and bed nucleus of the stria terminalis (BNST).  
Cat Fur Odor 
Lastly, studies have demonstrated the efficacy of using cat odor obtained directly from a 
domestic cat in the form of fabric rubbed against the fur. Previous research by McGregor and 
Dielenberg (1999) has demonstrated that in the presence of a live cat or cat odor, the rat will 
display specific risk assessment behaviors that allow the rat to investigate the impending threat. 
“Stretch-attend postures” include stretched attention and flat-back posture, as well as any 
behaviors that orient the rat in the direction of the threat (Kalynchuk et al., 2004). This behavior 
can be seen as somewhat ambivalent because the animal is conflicted between wanting to 
explore the stimulus and wanting to flee from the stimulus (van der Poel, 1979). The “head out” 
behavior is characterized by scanning the environment from the safety of a confined space (Siviy 
& Harrison, 2008). In addition, non-defensive behaviors, or behaviors that are not involved in 
readying the body for flight or fight, are inhibited during a potential predator attack. These 
behaviors include grooming, feeding, and play behavior (Staples, 2010). 
A single exposure to cat odor activates the medial hypothalamic defensive circuit 
(Canteras, 2002), including inputs from the olfactory system, the medial hypothalamus, the 
dorsal premammillary nucleus, the anterior hypothalamic nucleus, and the dorsomedial part of 
the ventral medial hypothalamus (Staples, 2010). Many mammals utilize the olfactory system in 
order to detect predators, although cat odor is processed primarily through the anterior olfactory 
nucleus, accessory olfactory bulb, and the medial amygdala. Cat odor is processed as a 
“kairomone” which is a chemical emitted by one type of species and detected by a different type 
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of species, allowing the latter species to prepare for immediate danger (Dicke & Grostal, 2001). 
Another region associated with anxiogenic-like behaviors is the BNST. Exposure to cat odor or a 
live cat increases amino acid protein expression in the BNST (Dielenberg, Hunt, & McGregor, 
2001). 
Advantages of the Cat Odor 
Rodents have evolved a sensitivity to feline cues that has led to the development of 
specific defensive behaviors toward these cues. The innate defensive response to cat odor is so 
strong that a rat will react to the odor even if it has never encountered a live cat. Using cat odor is 
advantageous over other predator exposure methods for a number of reasons. First, exposure to 
cat odor is consistent with the type of stimulus that would be encountered in the animal’s natural 
environment and induces innate, ethologically-relevant, unconditioned defensive behaviors 
(Wright et al., 2013). The rodent’s responses can be characterized as “phylogenetically prepared” 
and will effectively map the brain regions involved in anxiety. In addition, reactions to irrelevant 
stimuli such as pain and those not found in a rat’s natural environment are limited (Staples, 
2010). Second, using predator odor as a stressor stimulus allows for behavioral monitoring 
during the exposure, including quantifying the duration and frequency of certain assessments, 
which is not always possible with alternative stressor models including footshock and restraint 
(Wright et al., 2013). Third, the behaviors induced by cat odor resemble certain symptoms of 
human anxiety disorders including scanning and retreat (Dielenberg & McGregor, 2001). The cat 
odor induces responses that specifically parallel GAD, with increased vigilance and risk 
assessment. These responses are also indicative of anxious symptoms because they are 
attenuated by the administration of benzodiazepines (Staples, 2010). Finally, using cat odor to 
repel rats has stimulated research in both domestic and agricultural contexts (Dielenberg & 
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McGregor, 2001).   
The presence of predators or predator odors in the wild is a threatening experience for 
animals because there is a high probability they will get wounded or even killed (Muñoz-
Abellán, Andero, Nadal, & Armario, 2008). Thus, rats exposed to a cat demonstrate behavioral 
changes reflective of heightened anxiety (Blanchard & Blanchard, 1989). When tested on the 
EPM after odor exposure, rats display anxiogenic behaviors such as a reduction of time spent in 
the open arms. Fear of the open arms stems from a natural aversion to heights and open spaces. It 
has been demonstrated that rats exposed to cat odor as opposed to a live cat show similar signs of 
anxiety (McGregor & Dielenberg, 1999). According to McGregor and colleagues (2002), the 
type of odor used affects the type of response produced. In their experiment, rats displayed 
anxiogenic behavior in the EPM and suppressed locomotion in a novel environment immediately 
after exposure to a collar worn by a cat but not after exposure to TMT.  
 
Exposure Apparatus 
Hide Box 
 Currently, the most replicated predator exposure method is presenting the odor in a 
rectangular apparatus with a “hide box” (Takahashi, Hubbard, Lee, Dar, & Sipes, 2007; Siviy & 
Harrison, 2008; McGregor & Dielenberg, 1999; Kalynchuk et al., 2004; Campeau et al., 2008). 
The hide box is a compartment at one end of the chamber where the rat can hide and poke its 
head out. One of the purposes of the hide box is for the rat to retreat to a confined area 
immediately following detection of the odor. From the hide box, the rat can safely scan the 
environment from a “head out” posture. This behavior is a sensitive measure of risk assessment 
and an innate defensive mechanism occurring in a rat’s natural environment (Dielenberg, 
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Carrive, & McGregor, 2001).  
Home Cage 
 Although the literature involving the use of a hide box is extensive, the major limitation 
to this method is that the rat is likely to develop contextual fear to the apparatus. Using a testing 
chamber only allows for observation of anxiogenic responses in one context. In contrast, the 
current study will present the predator odor via worn cat collars and a towel in the home cage. 
Presenting the odor in the home cage allows for observation of anxiety that will potentially 
generalize to other contexts. Typically, presentation of the odor in the home cage is done via an 
impregnated cloth hung above or on top of the cage (Sütt et al., 2008; House, Vyas, & Sapolsky, 
2011). Several human anxiety disorders present a range of physical and psychological symptoms 
that are not restrictive to certain settings (McGrandles & Duffy, 2012). Therefore, the animal 
model of anxiety used in this study is more indicative of the many manifestations of human 
anxiety disorders.  
Based on previous research using predator exposures, there are several questions that 
remain unanswered which the current experiment will attempt to address. First, will repeated 
exposure to a predator odor alter behavior in a test of anxiety and a test of anhedonia, the core 
symptom of human depression? Exposure to a predator odor is a stress paradigm typically used 
to measure anxiety-like behaviors. However, due to the high comorbidity rate between anxiety 
and depression, it is reasonable to hypothesize that a chronic schedule of stress might also induce 
depressive-like behaviors. Second, will pretreatment with ketamine influence the presence of 
depressive and anxiety-like behaviors in rats? Ketamine administered in adolescence has been 
shown to attenuate depressive-like behaviors, but there is limited research regarding its effects on 
anxiogenic behaviors. Finally, will pretreatment with ketamine have a protective effect against 
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the stressor of being exposed to predator odor? The current study predicts that rats exposed to the 
predator odor will be more likely to display depressive-like behaviors and repeated ketamine 
administration will tend to reverse the effects of stress during adulthood. 
This study investigated the effects of chronic ketamine administration on anxiety and 
depressive-like behaviors after exposure to a predator odor in Sprague-Dawley rats. The main 
goal of the experiment was to examine how repeated exposure to a stressor affects long-lasting 
behavioral responsiveness in novel situations such as the elevated zero maze (EZM) and the 
sucrose preference test (SPT), and whether that can be reversed by ketamine administration.   
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Methods 
Subjects 
Twenty-four rats were used for this study. All rats were fed on an ad libitum (in 
accordance with desire) schedule. The rats were obtained at approximately 38 days old. All 
animals were subjected to gentle handling once a day for three consecutive days prior to the 
experiment. They were double housed in the Jubilee Hall vivarium on a 12/12h light/dark cycle. 
Approval of the Seton Hall Institutional Animal Care and Use Committee was obtained before 
the start of any experimental procedures. 
Apparatus  
Predator Odor Exposure 
Predator odor exposure took place in the rats’ home cages, as previously described in 
House et al. (2011). The home cage was a clear Plexiglas chamber with four walls [44 cm (L) x 
24 cm (W) x 22 cm (H)] with corn cob bedding and a wire grate top for access to rat chow and 
water. There was a combined method of predator exposure: a worn cat collar and a towel 
impregnated with cat odor. Worn cat collars were “Breakaway” safety stretch cat collar (Great 
Choice, China) and were obtained from two domestic, female cats that wore the collars for 
approximately four weeks. Upon removal from the cats, the collars were placed in separate 
airtight plastic containers and were stored in a freezer at 0° C. On the day of testing, the collars 
were cut into 9-cm pieces with one piece being used in each home cage. A binder clip was 
placed in each home cage one inch away from the water bottle spout. The collar pieces were 
attached to the binder clips 12cm above the floor of the home cage. Only the pieces of collar that 
came in direct contact with the cat’s fur were used. At the start of the trials, the collar was 
“warmed up” by placing it on top of a heater for approximately two minutes. The cat collar was 
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always handled with latex gloves. Four collars were used for this experiment: two cat odor 
collars and two control collars. 
A cotton hand towel (60 cm x 40 cm) was also used to present the cat odor. The towels 
were placed in the cat’s sleeping spot for one night and rubbed against the cat’s body the 
following morning. Upon acquisition, the towels were placed in separate airtight plastic 
containers and stored in a freezer at 0° C. Twelve towels were used for this experiment: six 
towels impregnated with cat odor and six control towels. The experimental and control towels 
were always handled with latex gloves.  
Sucrose Preference Test 
The SPT apparatus is a metal cage with a wooden top [22 cm (L) x 27 cm (W) x 30 cm 
(H)]. A wooden apparatus that holds the bottles in place was situated next to the front of the 
metal cage. The SPT measures the consumption of sweet food or drink to assess anhedonia 
(Abelaira et al., 2013), the core symptom of human depression (Kumar, Kuhad, & Chopra, 
2011). An advantage of the SPT is that unlike other behavioral measures, it is not dependent on 
motor activity. Although the task’s procedures can vary, the most common way to employ the 
SPT is by allowing the rats to choose between a bottle containing sucrose and a bottle containing 
tap water (Strekalova & Steinbusch, 2010). The rats are typically subjected to an acclimatization 
period (Dagyte et al., 2011) where they are trained to consume the sucrose solution (Wang, 
Zhang, Hui, Zhang, & Hu, 2013) and then deprived of food and water prior to testing so as to 
motivate them to drink.  
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Elevated Zero Maze 
 The apparatus was comprised of a black, annular platform (100 cm diameter, 10 cm 
width) elevated to 40 cm above ground level. Two quadrants are enclosed by black cardboard 
walls (29 cm high) and the other two quadrants remain open. Exploration in the EZM is an 
unconditioned test of anxiety-like behavior (Sütt et al., 2008), originally described by Shepherd, 
Grewal, Fletcher, Bill, and Dourish (1994). Rats have a natural aversion to heights and open 
spaces and therefore will display fear reactions such as freezing and increased plasma CORT 
levels when placed in the open arms. As a consequence of the aversive nature of the open arms, 
the rats will spend a greater amount of time, on average, in the closed arms (Shepherd et al., 
1994). The zero maze has a major advantage over the EPM: there is no center region. In the 
EPM, the amount of time spent in the center square of the “plus” shape is difficult to interpret 
because the behavior is neither indicative of anxiety nor locomotion. Because the zero maze is 
circular in shape, the center platform is eliminated along with any ambiguity in interpretation 
(Cook, Williams, & Flaherty, 2001). The zero maze has been pharmacologically validated with 
anxiolytic drugs. For example, Braun, Skelton, Vorhees, and Williams (2011) found that 1mg/kg 
of diazepam significantly increased time spent in the open arms of the maze. 
Figure 1. Photograph of the Sucrose Preference Test used in this study  
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Drugs 
Ketamine was obtained from JHP Pharmaceuticals, LLC, Rochester, MI 48307 (NDC 
420023-138-10). One group of rats received 25 mg/kg of ketamine daily (n =12), 
intraperitoneally (ip), prepared in saline at a volume of 1 mL/100 g while another group of rats (n 
= 12) received daily injections of 25 mg/kg of saline (ip).   
Procedure 
During rat adolescence on PND 45, twelve of the twenty-four rats received a 25mg/kg 
injection of ketamine for a total of seven consecutive days. The other twelve rats received a 
25mg/kg injection of saline, also referred to as vehicle. On PND 51-62, the animals were 
subjected to object recognition testing that was a part of a separate study. During young 
adulthood on PND 65, animals were divided into four groups for the cat odor exposure based on 
the previous ketamine pretreatment: ketamine pretreatment + cat odor (n = 6), ketamine 
pretreatment + control odor (n = 6), vehicle pretreatment + cat odor (n = 6), and vehicle 
pretreatment + control odor (n = 6). The animals were then carried in their home cages to the 
testing room. The rats remained double-housed (two rats per cage) during the entirety of the 
Figure 2. Photograph of the Elevated Zero Maze used in this study  
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experiment. Each cage mate received a different drug administration but both rats received the 
same type of odor exposure. Without removing the rats from their home cages, the collar piece 
was attached to the binder clip and the cloth was draped over the top of the cage. Twelve 
experimental rats were exposed to the predator odor and twelve control rats were exposed to the 
control odor in the home cage for a 30-min period. The collar piece and cloth were removed 
immediately after the 30-min session and the rats were carried back to the housing room. This 
procedure was repeated twice at 24-hour intervals for a total of three predator or control odor 
exposures. Odor exposure sessions were conducted in a separate testing room to avoid exposing 
other rats to the cat odor.  
One day after the last predator exposure, the SPT began. The predator odors were not 
present during the SPT because the goal of this task was to assess the presence of depressive-like 
behaviors that might have developed as a result of the odor exposure. The SPT was conducted 
during adulthood from PND 68 to PND 71, a total of four days due to staggering the procedures 
across the four groups. The task was composed of habituation, deprivation and testing (Kumar et 
al., 2011). During habituation, the animals were trained to consume a 3% sucrose solution in the 
test apparatus for a 2-h period. Animals were presented simultaneously with two bottles, one 
containing 3% sucrose solution and the other containing tap water (Bhagya et al., 2011). The 
volume of sucrose and water intake was measured at the end of the two hours. After habituation, 
rats were deprived of water for 14h. Immediately after deprivation, the rats were put back into 
the sucrose chamber and preference for 3% sucrose was assessed during a 2-h test session. 
During this test session, rats were able to freely choose between two bottles: 100 ml of 3% 
sucrose solution and 100 ml of tap water. The habituation and test phases took place in an 
apparatus separate from the home cage. To prevent the possibility of side preference in drinking 
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behavior, the bottles were reversed at the midway point of both phases. The amount of liquid 
remaining in each bottle was measured at the end of the test phase. The preference for sucrose 
was calculated as a percentage of the consumed sucrose solution from the total amount of liquid 
drank from the formula: 
SP =                        sucrose intake (g)                        x 100 
[sucrose intake (g) + water intake (g)] 
 
The SPT was conducted before the EZM to avoid any confounding stress that the latter 
measure might induce. 
EZM testing began on the following day, during adulthood on PND 72 and 73. After each 
rat was placed in the apparatus, an observer stood 2m from the maze to record behavioral 
responses. Behavior of rats was recorded for one 5-min session and the following measures were 
taken: number of open quadrant entries, amount of time spent in the open quadrant(s), number of 
closed quadrant entries, and amount of time spent in the closed quadrant(s). Behavior was also 
videotaped with a camera suspended above the apparatus. Percentage scores were calculated for 
open-quadrant time (i.e., time in open quadrant/total time in any quadrant x 100) and open-
quadrant entries (i.e., number of entries into the open quadrants/total number of entries into any 
quadrant x 100) similar to previous studies (Engin et al., 2009; Pellow, Chopin, File, & Briley, 
1985; Engin, Stellbrink, Treit, & Dickson, 2008). Percent time spent in open quadrants is the 
most accepted scoring variable used to reflect decreased anxiety (Lister, 1987; Shepherd et al., 
1994). A higher percentage of open quadrant time or open quadrant entries, in the absence of 
changes in general activity, was taken as indicators of anxiolysis. Number of closed quadrant 
entries and total number of quadrant entries both served as measures of general activity in the 
zero maze. In an attempt to control for a possible lack of movement around the maze due to 
novelty, animals were exposed to the EZM on two consecutive days. The SPT and EZM were 
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conducted during adulthood to investigate whether the adolescent ketamine treatment had long-
lasting effects (Table 1). 
 
Table 1: Timeline of Experimental Procedures 
PND Description of Procedures 
45-51              Ketamine injections Animals received 25 mg/kg (ip) of ketamine (n 
= 12) or saline (n = 12) once daily 
51-62              Object recognition Object recognition testing (separate study; data 
not shown) 
63-64              Rest Rest 
65                   Odor exposure (30 min) Four groups: ketamine pretreatment + cat odor 
(n = 6), ketamine pretreatment + control (n = 
6), vehicle pretreatment + cat odor (n = 6), and 
vehicle pretreatment + control (n = 6) 
66                   Odor exposure (30 min) Same as day 65 
67                   Odor exposure (30 min) Same as day 65 
68                   SPT: Habituation Trained to consume 3% sucrose in the 
apparatus for 2h 
69 or 70         SPT: Deprivation Deprived of water for 14h 
70 or 71         SPT: Test Assessed preference for sucrose in the 
apparatus for 2h 
72                   EZM: Day 1 One 5-min session 
73                   EZM: Day 2 One 5-min session 
 
Statistical Analysis 
The behavioral responses recorded in the EZM and SPT were analyzed with analyses of 
variance (ANOVA). Seven 2 (drug administration) x 2 (predator odor) between-groups ANOVA 
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were conducted. Partial η2 was reported as a measure of effect size for each variable (Richardson, 
2011). Cohen (1988) suggested that small, medium, and large effects would correspond to values 
of η2 of .0099, .0588, and .1379, respectively. A p value of <0.05 indicated statistical 
significance throughout. 
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Results 
Sucrose Preference Test 
Habituation 
 Preference for 3% sucrose was measured during the habituation and test phases. A two-
way between-groups ANOVA did not reveal a significant effect of drug administration, F(1, 23) 
= .495, p = .490, partial η2  = .024; type of odor, F(1, 23) = 1.065, p = .314, partial η2  =.051; or 
drug x odor interaction, F(1, 23) = 3.497, p = .076, partial η2  = .149 during habituation. 
However, the drug x odor interaction effect was trending toward significance with a large effect 
size. This interaction appeared to be the result of a reduction in sucrose preference after predator 
odor exposure in the vehicle group but not the ketamine group (Figure 3). Absolute intakes were 
calculated for each condition, indicating that, on average, rats consumed more sucrose than water 
(Table 2). 
 
Figure 3.       Average sucrose preference during the habituation phase of rats administered 
ketamine or vehicle. Dark gray bars represent the preference of rats exposed to predator odor; 
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light gray bars represent the preference of rats exposed to control odor. Error bars represent 
standard error of the mean. 
 
 
 
Table 2.  Absolute Sucrose and Water Intakes for Habituation 
 Sucrose Intake Water Intake 
Ketamine + Predator Odor 95.7±1.6ml 16.9±0.2ml 
Ketamine + Control Odor 72.7±1.5ml 28.6±0.4ml 
Vehicle + Predator Odor 59.9±2.0ml 35.8±0.4ml 
Vehicle + Control Odor 79.2±1.0ml 26.9±0.1ml 
 
Test 
After a 14h period of water deprivation, preference for 3% sucrose was measured again 
during the test phase. A two-way between-groups ANOVA did not reveal a significant effect of 
drug administration, F(1, 23) = .691, p = .416, partial η2 = .033; type of odor, F(1, 23) = .021, p = 
.886, partial η2 = .001; or drug x odor interaction, F(1, 23) = 1.784, p = .197, partial η2 = .082 
(Figure 4). Absolute intakes revealed that, on average, rats consumed more sucrose than water 
(Table 3). Additionally, absolute intakes for the treatment groups were higher during the test 
phase compared to the habituation phase. 
 
 	   32	  
 
Figure 4.       Average sucrose preference during the test phase of rats administered ketamine or 
vehicle. Dark gray bars represent the preference of rats exposed to predator odor; light gray bars 
represent the preference of rats exposed to control odor. Error bars represent standard error of the 
mean. 
 
Table 3.  Absolute Sucrose and Water Intakes for Test 
 Sucrose Intake Water Intake 
Ketamine + Predator Odor 33.3±1.4ml 7.2±0.9ml 
Ketamine + Control Odor 36.1±2.8ml 11.4±1.3ml 
Vehicle + Predator Odor 30.3±2.6ml 13.1±1.9ml 
Vehicle + Control Odor 45.5±2.3ml 10±1.5ml 
 
Change Scores 
 To address the variability in sucrose consumption during habituation across rats, change 
scores in sucrose preference percentage were used to calculate changes in preference from 
0	  10	  20	  
30	  40	  50	  
60	  70	  80	  
90	  100	  
Ketamine	   Vehicle	  
Average	  
Sucrose	  
Preference	  
Drug	  Administration	  
Effect	  of	  Odor	  Type	  and	  Drug	  
Administration	  on	  Sucrose	  Preference	  
during	  Test	  
Predator	  Control	  
 	   33	  
habituation to test. A two-way between-groups ANOVA did not reveal a significant difference of 
drug administration, F(1, 23) = .425, p = .522, partial η2 = .021; type of odor, F(1, 23) = 1.124, p 
= .302, partial η2 = .053; or drug x odor interaction, F(1, 23) = .763, p = .393, partial η2 =.037 
(Figure 5).  
 
         
Figure 5.      Change in average sucrose preference from habituation to test of rats administered 
ketamine or vehicle. Dark gray bars represent the preference of rats exposed to predator odor; 
light gray bars represent the preference of rats exposed to control odor. Error bars represent 
standard error of the mean. 
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partial η2 = .000; or drug x odor interaction, F(1, 23) = .317, p = .580, partial η2 = .016 on the 
first day of EZM exposure (Figure 6). 
   
Figure 6. Percent of total EZM session spent in the open quadrants. Dark gray bars 
represent the percentage score of rats exposed to predator odor; light gray bars represent the 
percentage score of rats exposed to control odor. Error bars represent standard error of the mean. 
 
 
Number of Open Quadrant Entries 
 A two-way between-groups ANOVA did not reveal a significant effect of drug 
administration, F(1, 23) = .217, p = .646 partial η2 = .011; type of odor, F(1, 23) = .217, p = .646, 
partial η2 = .011; or drug x odor interaction, F(1, 23) = .217, p = .646, partial η2 = .011 (Figure 
7).  
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Figure 7.       Percent of total EZM entries into the open quadrants. Dark gray bars represent the 
entry percentage of rats exposed to predator odor; light gray bars represent entry percentage of 
rats exposed to control odor. Error bars represent standard error of the mean. 
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 Due to the finding that rats only rarely left the closed quadrants of the EZM on the first 
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determine whether their lack of exploration on day 1 was the result of being placed into a novel 
environment and would attenuate with a second exposure to the apparatus. A two-way between-
groups ANOVA did not reveal a significant effect of drug administration, F(1, 23) = .624, p = 
.439, partial η2 = .030; type of odor, F(1, 23) = 4.076, p = .057, partial η2 = .169; or drug x odor 
interaction, F(1, 23) = .624, p = .439, partial η2 = .030 (Figure 8). However, the main effect of 
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odor tended to spend more time in the open quadrants (M = .389, SD = .681) than the animals 
exposed to the predator odor (M = .000, SD = .000). 
 
Figure 8.       Percent of total EZM session spent in the open quadrants. Error bars represent 
standard error of the mean. 
 
Number of Open Quadrant Entries 
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significant effect of drug, F(1, 23) = .000, p = 1.00, partial η2 = .000 or significant drug x odor 
interaction, F(1, 23) = .000, p = 1.000, partial η2 = .000 (Figure 9). 
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Figure 9.       Percent of total EZM entries into the open quadrants. Error bars represent standard 
error of the mean. 
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Discussion 
 
 The purpose of this study was to investigate the effects of chronic ketamine 
administration on anxiety and depressive-like behaviors induced by a predator odor. The results 
indicated a drug x odor interaction effect in the habituation phase of the SPT that was trending 
toward significance with a large effect size. This interaction appeared to be the result of ketamine 
tending to reverse the decrease in sucrose preference as a result of the predator odor exposure. 
However, neither ketamine exposure nor exposure to predator odor significantly influenced the 
average sucrose preference during the test phase. Additionally, these variables did not 
significantly affect the change in sucrose preference from habituation to test.  
Findings from the first day of EZM did not reveal any significant effects of drug, odor, or 
their interaction. However, the second day of EZM testing revealed a significant main effect of 
odor type on anxiety. Animals exposed to the predator odor made significantly fewer entries into 
the open quadrants than the animals exposed to the control odor. Additionally, the main effect of 
odor for the percentage of time spent in the open quadrants was trending toward significance. 
The large effect size suggests that animals exposed to the predator odor tended to spend less time 
in the open quadrants compared to animals exposed to the control odor.  
Although predator odor is typically used exclusively in a model of anxiety, the current 
study investigated whether repeated exposure would also induce depressive-like behaviors. 
Previous research suggests that the onset of depression is due in part to the accumulation of 
stressful life events, and that stressful life events are associated with an increase in depressive 
symptoms (Mazure, 1998; Stroud, Davila, & Moyer, 2008; Abela & Skitch, 2006). Analyses of 
the four groups revealed a drug x odor interaction trending toward significance during the 
habituation phase of the SPT; this suggests that adolescent ketamine administration tended to 
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reverse the decrease in sucrose preference due to the predator odor exposure. Although this 
finding is not statistically significant, the large effect size suggests that the effect is meaningful. 
This finding is in line with research from Xi and colleagues (2011) in which escitalopram 
treatment reversed the effect of chronic unpredictable mild stress (CUMS) in the SPT. 
The present results reveal the long-lasting effects of ketamine administration on sucrose 
preference, which was measured almost 20 days after drug administration. This is consistent with 
work from Ma and colleagues (2013) who found that a single administration of ketamine tended 
to increase preference for sucrose 24 hours, 4, 6, and 8 days later. It is important to note that the 
drug was no longer in the animals’ systems during the predator exposure. Therefore, it is 
possible that any effect of ketamine was due to neural changes that happened as a consequence 
of repeated ketamine administration during adolescence. This is consistent with research from 
Parise and colleagues (2013) who found that ketamine administration in adolescence tended to 
reverse the effects of CUS-induced depressive-like behaviors in the FST in adulthood. 
In contrast to the habituation phase, the test phase did not yield any statistically 
significant or trending effects. Although the reasons for this are unclear, it is noteworthy that the 
only manipulation that occurred after the habituation phase was the 14h water deprivation. It is 
possible there was some degree of neophobia on the habituation day that went away on test day. 
This is evident when comparing the sucrose preference for the vehicle + predator odor group 
over time. The mean sucrose preference for this particular group of rats increased slightly from 
habituation to test, although not significant. Perhaps the predator odor very subtly affected the 
initial reaction to the new environment, which is why it was only evident during the first day in 
the sucrose chamber. There is no doubt this is a small effect in terms of the animals’ behavior, 
but it could indicate their anxiety about a novel liquid. Finally, the absolute intakes for the 
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treatment groups were higher in the test phase compared to the habituation phase indicating that 
the deprivation period was sufficient. 
Another possibility for why the habituation phase showed a stronger effect is because the 
odor exposure occurred one day prior to this phase. In contrast, the odor exposure occurred three 
days prior to the test phase. Analysis of the change in sucrose preference from habituation to test 
did not reveal any significant findings. The reason the change scores were calculated is because 
perhaps there was too much individual variability, which masked any significant group 
differences. Small sample sizes (n = 6 rats per group) in the present study could be responsible 
for much of this variability. A power analysis using G*Power software was conducted to 
determine the probability of detecting an effect when it exists. G*Power indicated that 51 rats 
were an appropriate sample size for this experiment based on a specified statistical power of .8, 
an alpha level of .05, and a partial η2 of .14. Due to limited resources, this sample could not be 
achieved and thus contributed to the lack of power to detect any differences. 
One area of concern in the current experiment is that a 3% sucrose solution was used 
compared to much of the literature that uses a 1% solution. The reason for this deviation from 
standard protocol is because pilot testing with 1% and 2% sucrose revealed minimal average 
consumption over a two-hour period (M1% = 5.00g and M2% = 7.75g). Therefore, a 3% solution 
(M3% = 9.35g) was used to ensure the rats would be motivated to drink the sucrose. It is possible 
that the 3% solution was too concentrated which is why the rats in both the habituation and test 
phases drank more sucrose than water. This was not a completely novel paradigm as other 
studies have also used 3% solutions or higher (Diaz et al., 2013; Choi et al., 2013; Kosten & 
Meisch, 2013). Finally, the total amount of consumption could not be attributed to side 
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preference because this was accounted for by switching the location of the bottles halfway 
through the habituation and test phases. 
The EZM was used to measure anxiogenic responses after exposure to the predator odor. 
There were no significant differences in percent of time spent in the open quadrants and percent 
of open quadrant entries between the four groups on the first day of EZM testing. Overall, the 
animals were reluctant to move as evident by an overwhelming 79% of rats that never left the 
closed quadrants. The present results are not consistent with other findings that demonstrate 
substantial movement in and out of the quadrants. For example, Soares and colleagues (2013) 
investigated the effects of early protein malnutrition and environmental stimulation on 
behavioral parameters in rats submitted to two five-minute sessions in the EPM. They found that 
malnourished (MN) rats displayed higher mean percentages of time in the open arms and made 
more entries, on average, into the open arms compared to well-nourished rats. The MN rats spent 
approximately 30% of the time in the open arms and made 30% of their total entries into the 
open arms, compared to the current study in which the vehicle + predator odor group spent 
approximately 1% of the time in the open quadrants and made 7% of their total entries into the 
open quadrants.  
A potential contributing factor for the lack of movement on day 1 of EZM testing is the 
possibility of a floor effect. This lack of movement was unanticipated; pilot testing with the same 
strain of rat demonstrated a great deal of entries and time spent in the open quadrants. Another 
possibility is that the novelty of the environment induced anxiety which led to less exploration, 
on average, among all the rats. This concern was addressed by conducting a second day of 
testing with this measure. Differences in rat strain between studies could have been a 
contributing factor (Hogg, 1996). Ferguson and Grey (2005) found evidence for strain and sex 
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differences among three types of rats in the EPM. Spontaneously hypertensive rats were 
significantly more active in the EPM compared to Sprague-Dawley and Wistar rats. 
Additionally, at PND 70, female rats of all strains displayed less time, on average, in the closed 
quadrants than their male counterparts. It is clear that different rat strains have a major impact on 
the outcome of this animal measure of anxiety. Perhaps there might have been more activity in 
the EZM had the Sprague-Dawley rats been female as opposed to male rats.   
 Despite the lack of significant effects during the first day of EZM testing, there was a 
significant effect of odor type on the percent of open quadrant entries on the second day. Rats 
exposed to the control odor made significantly more entries into the open quadrants than the rats 
exposed to the predator odor. This is consistent with my hypothesis that the predator odor would 
induce anxiety-like behavior, thus preventing the animals from leaving the safety of the closed 
quadrants. This finding is in accordance with previous research conducted by Sütt and colleagues 
(2008) who investigated the role of the endocannabinoid system in cat odor-induced anxiety in 
rats. Exploratory behavior of rats in the EZM showed a dramatic mean reduction of open-
quadrant entries, line crossings, and time spent in the open quadrants after cat odor exposure. 
Additionally, Campos, Piorino, Ferreira, and Guimarães (2013) investigated whether the 
behavioral changes induced by predator exposure are associated with changes in the medial 
prefrontal cortex nitrergic system (mPFC). They found that the animals exposed to a live cat 
displayed a decreased mean percentage of open arm entries in the EPM and an increased average 
number of nitric oxide synthase positive neurons in the mPFC. 
The effect of odor type on percentage of time spent in the open quadrants was trending 
toward significance. Rats exposed to the control odor spent more time, on average, in the open 
quadrants compared to the rats exposed to the predator odor. This is consistent with my 
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hypothesis that the control odor groups would not tend to display anxiogenic behaviors and 
therefore would be more likely to actively explore the environment. Of particular importance is 
the fact that the odor exposure occurred a week prior to EZM testing. The presence of a main 
effect of odor a week later demonstrates the long-lasting effect of this stress paradigm in the 
EZM. Although much of the literature with predator odor tends to examine immediate behavioral 
and physiological effects, there is one study, in particular, that examined delayed behavioral 
effects to various types of odor. Muñoz-Abellán and colleagues (2008) found that rats exposed to 
cat fur odor tended to show signs of anxiety-like behavior in the EPM one week after initial 
stress exposure. This did not occur for rats exposed to alternative stressors including cat urine or 
immobilization in wooden boards.  
Although there were significant effects of odor on the second day of EZM testing, it is 
possible that greater exposure to the odor may have produced more robust effects that would 
have also been evident on the first day of testing. The goal of the present study was to expose the 
animals to a chronic schedule of the predator odor in order to investigate its long-lasting effects. 
Therefore, the odor was presented three times over three consecutive days, which is considered a 
chronic schedule. Much of the literature on predator exposure employs only one exposure 
session and assesses the presence of anxiety-like behaviors during the exposure (Siviy & 
Harrison, 2008; Kalynchuk et al., 2004) or within 24-h of the exposure (Sütt et al., 2008; 
Takahashi et al., 2007). While this research is able to examine the immediate effects of the 
predator odor, it cannot draw conclusions regarding effects lasting for longer than a few days. 
The present study was able to demonstrate the long-lasting effects of the predator odor exposure 
five days later on the second day of EZM testing.  
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There are numerous ways to induce stress in a rat including repeated CORT injections 
(Kalynchuk et al., 2004), chronic psychosocial stress models (Slattery et al., 2012), and repeated 
footshock (Kassai & Gyertyán, 2012). It is important to note that the current study used a less 
invasive method so as to reduce the amount of harm to the animals. Several concerns can be 
considered with regard to using the predator odor method compared to more invasive methods. 
First, it is possible that the rats learned to avoid the area with the aversive collar piece after initial 
contact. This is problematic because it reduces the amount of time the rat is exposed to the 
threatening stimulus. For example, Dielenberg and McGregor (2001) reported that the rats in 
their study spent only 7s out of 1200s sniffing the cat odor stimulus, which was not long enough 
to induce amino acid expression in the olfactory bulb. Second, because the odor was presented 
via a collar piece and a towel, it had the disadvantage of being diffused throughout the room. A 
more contained method of odor exposure is using TMT, which is typically presented via a filter 
paper soaked with the odor. Additionally, this method has the advantage of being able to use a 
new filter paper for each animal, thereby ensuring a potent odor with every use (Hacquemand et 
al., 2013).  
 The current study wanted to investigate whether the anxiogenic effect of the predator 
odor would generalize to a context in which the rat did not experience the odor. The results 
demonstrated that the odor exposure in the home cage did, in fact, generalize to the EZM. This is 
in accordance with an experiment conducted by Dielenberg and McGregor (2001) who found a 
transfer of defensive behaviors from the avoidance apparatus to the EPM in rats exposed to cat 
odor but not rats exposed to TMT or triethylamine. Evidence for the effectiveness of the predator 
odor method came from inspection of the collars after each exposure. Upon removing collar 
pieces from the home cages, careful observation revealed that the control collars had a 
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significant amount of chew marks. The cat collars, on the other hand, were not chewed and 
looked like they were completely avoided. This is consistent with Sütt and colleagues (2008) 
findings which revealed that none of the animals touched the cat odor-impregnated cloth during 
predator odor exposure. 
As previously mentioned, there is a high comorbidity rate between disorders of anxiety 
and depression. Although there exists a great deal of inconsistencies regarding the actual 
percentage of this comorbidity, there is agreement that this co-occurring pattern of illnesses is 
fairly common. The findings from the current animal model of anxiety provide minimal evidence 
for the overlap between the characteristics of these two disorders as a result of exposure to the 
stressor of predator odor. Although the odor induced marginal effects on sucrose consumption 
during SPT habituation and the second day of EZM testing, these effects were not robust. In 
addition, adolescent exposure to ketamine affected SPT results but not EZM, indicating 
dissociation between ketamine’s effects on models of depression and anxiety.  
Despite the effects that were inconsistent with previous studies, there is still a productive 
line of research for future experiments. The next step in the line of research would be to validate 
this ketamine pretreatment with other measures of depression. Because ketamine showed a 
trending effect on sucrose preference, it is worth investigating if this effect can be found in other 
animal models of depression such as the FST or TST. Although pretreatment with ketamine did 
not significantly influence anxiety-like behaviors, an effect of this drug might be present in an 
alternative measure of anxiety, such as the social interaction test. Therefore, future studies should 
incorporate multiple measures of anxiety and depression, which are lacking from the current 
experiment. Due to the unanticipated lack of movement on the first day of EZM testing, future 
research should include more exposure to the maze. Although much of the literature employs a 
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single 5-min exposure, future studies could increase the amount of time spent in the maze as well 
as the number of maze exposures.  
In summary, the present results provide some evidence for the preventative effects of 
ketamine on depressive-like behaviors. The repeated schedule of ketamine in adolescence 
appeared to have subtle but prolonged effects that were evident in adulthood. Of particular 
significance is the fact that ketamine tended to prevent the presence of depressive-like behaviors 
in the SPT. The role of ketamine in predator odor-induced fear conditioning suggests the 
possibility that various glutamate receptor antagonists may be effective agents for reducing the 
symptoms of depression. Recreational and prescription drugs are widely abused during 
adolescence, which can result in altered psychological functioning during adulthood. This raises 
the question of whether psychiatric medication administered during adolescence can prevent the 
presence of certain disorders later in life. The present results tell us that pretreatment with 
ketamine should be considered as a potential pharmacotherapy for clinical depression. Further 
research regarding the pharmacological modulation of the response to cat odor is necessary in 
identifying new drugs that are useful in treating human anxiety and depressive disorders. 
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